Indian Drug Giant Sun Pharma Has Another Major Product Recall, an Industrial Info Market Brief
Indian Drug Giant Sun Pharma Has Another Major Product Recall, an Industrial Info Market Brief
Attachment: sun pharma
Sun Pharma has issued yet another product recall, albeit a voluntary one this time. The action concerns 140 cases (14,000 doses) of Vecuronium Bromide for Injection, a drug used for anesthesia, after the drug was found to contain particulate matter identified as glass.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- An Ounce of Prevention is Worth a Pound of Cure as Pharma-Bio Industry Inve...
- ISPE Names the 2015 Pharmaceutical Facility of the Year Category Awards
- Ontario to See $3.66 Billion in Project Construction Starts in Second-Quart...
- U.S. Supplement Production Brings Millions in Spending
- Samsung Biologics Constructing ADC Plant in South Korea